Medical technology company Aidoc has recently raised $150m from backers including General Catalyst to continue improving its medical diagnostics technology. Aidoc currently serves over 45 million patients per year, and aims for its technology to cover and detect every disease in three years’ time. Fresh off closing the latest funding round, Aidoc CEO Elad Walach spoke to Tom Mackenzie on ‘Bloomberg: The Pulse’.
